PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
PRDS
Delisted
PRDS was delisted on the 30th of August, 2023.
57 hedge funds and large institutions have $282M invested in Pardes Biosciences, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
51% less capital invested
Capital invested by funds: $573M → $282M (-$291M)
Holders
57
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$22M | |
| 2 | +$15.3M | |
| 3 | +$8.96M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.12M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$2.66M |
Top Sellers
| 1 | -$40.2M | |
| 2 | -$16.4M | |
| 3 | -$10.1M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$9.74M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.91M |